Leslie Meltzer
Chief Research and Development · 2 filings · Latest: May 14, 2026
Apellis Pharmaceuticals, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|
Chief Research and Development · 2 filings · Latest: May 14, 2026
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|